Skip to main content

Request For Trial Preservation Depositions in DePuy Hip MDL

Request For Trial Preservation Depositions in DePuy Hip MDL

Request For Trial Preservation Depositions in DePuy Hip MDL

Introduction

In a supplemental memorandum filed on June 18, the plaintiffs in the DePuy hip multidistrict litigation requested permission to conduct trial preservation depositions for 11 defense witnesses. The plaintiffs asserted that the ongoing discovery, revelations, and new scientific literature warrant such depositions. The request was filed in the U.S. District Court for the Northern District of Texas.

DePuy and its parent corporation, Johnson & Johnson have been accused of failing to warn about device dislocation, loosening, and metallosis often requiring revision surgery. More than 9,400 Pinnacle hip lawsuits are pending in the federal court.

Other hip implant lawsuits include cases against Stryker hip replacement systems which are consolidated as a part of multidistrict litigation, MDL No. 2768 ( In Re: Stryker LFIT V40 Femoral Head Products Liability Litigation) in the United States District Court for the District of Massachusetts before U.S. District Judge Indira Talwani.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!